Intention to have blood-based multi-cancer early detection (MCED) screening: a cross-sectional population-based survey in England

Author:

Schmeising-Barnes Ninian,Waller Jo,Marlow Laura A. V.ORCID

Abstract

Abstract Background Trials assessing the clinical utility of blood-based multi-cancer early detection (MCED) tests are underway. Understanding public attitudes towards MCED screening is essential if these tests are to be used. We aimed to quantify MCED screening intention and potential barriers and facilitators to uptake. Methods Adults aged 50–77 (n = 958) completed an online survey. The primary outcome was intention to have MCED screening if offered. Psychological variables including barriers and facilitators were assessed. We used logistic regressions to explore associations between socio-demographics and psychological factors and intention. Results 93.8% of participants said they would ‘definitely’ or ‘probably’ have MCED screening if offered. Intention was significantly associated with previous screening participation and general cancer attitudes but not with socio-demographic factors. Participants were more likely to be intenders if they had higher health motivation, and perceived greater benefits of blood tests. Participants were less likely to be intenders if they perceived greater disadvantages of blood tests, more practical barriers, were more worried about the outcome and more concerned about a positive result. Conclusions and implications MCED screening intention was high. The lack of socio-demographic variation suggests equitable interest in this type of screening; however, future research should consider how intention translates to uptake.

Funder

This work was supported by GRAIL Bio UK Ltd through a contract with King's College London/Queen Mary University of London.

Publisher

Springer Science and Business Media LLC

Reference50 articles.

1. NHS Digital. Cancer Survival in England, cancers diagnosed 2015 to 2019, followed up to 2020 2022 [Available from: https://digital.nhs.uk/data-and-information/publications/statistical/cancer-survival-in-england/cancers-diagnosed-2015-to-2019-followed-up-to-2020/cancer-survival-by-stage]. Accessed April 2024.

2. World Health Organisation. Promoting cancer early diagnosis 2024 [Available from: https://www.who.int/activities/promoting-cancer-early-diagnosis] Accessed April 2024.

3. NHS. The NHS Long Term Plan. 2019. [Available from: https://www.longtermplan.nhs.uk/publication/nhs-long-term-plan/] Accessed August 2024.

4. NHS Digital. Routes to Diagnosis, 2018 2022 [Available from: https://digital.nhs.uk/data-and-information/publications/statistical/routes-to-diagnosis/2018]. Accessed April 2024.

5. NHS. NHS Screening 2024 [Available from: https://www.nhs.uk/conditions/nhs-screening/]. Accessed April 2024.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3